| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.071 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |